-ThePrint.in Study titled 'India Needs To Learn — A Case for Keeping Schools Open' conducted by Boston Consulting Group and Teach For India, with recommendations from over 35 organisations. New Delhi: Over 90 per cent of teachers in India have faced serious challenges with assessing student learning and over 80 per cent teachers expressed impossibility of maintaining an emotional connect with children during online classes, a study has found. The study, titled “India...
More »SEARCH RESULT
Total Matching Records found : 55
On Covid patents waiver, health cannot be held hostage to profit -Rajshree Chandra
-The Indian Express Innovation in vaccine production can have an impact only if it is accessible to all. Patents and access to life-saving drugs has always been an emotive and contentious issue. The right to healthy life is a moral minimum, and to find a rational basis to deny it is deeply offensive to the idea of life itself. At the same time, pharma corporations and institutions claim patents are a just...
More »Dengue death: Fortis kept profit margin as high as 1,737 per cent, finds NPPA -Abantika Ghosh
-The Indian Express Aadya died of dengue at the hospital in September, and her family was charged almost Rs 16 lakh for a 15-day stay. New Delhi: Fortis Hospital, Gurgaon made a 1,737 per cent profit on drugs and other consumables that it billed the family of seven-year-old Aadya Singh, the drug pricing regulator has found in an analysis. Aadya died of dengue at the hospital in September, and her family was charged...
More »Shore up supply of critical drugs, govt tells pharma industry -Teena Thacker
-Livemint.com Govt plans to?help firms revamp manufacturing units,?refurbish machinery,?ensure subsidized power in bid to produce drugs such as penicillin at competitive rates New Delhi: The Department of Pharmaceuticals (DoP), during a meeting on Wednesday, urged pharma companies to strive for self-sufficiency in critical drugs like penicillin, rifampicin and insulin, in a sign of government concern over India’s dependence on Chinese imports. A large number of so-called active pharmaceutical ingredients (APIs), or bulk drugs,...
More »Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer
-TheWire.in In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla’s product infringed its patented anticancer drug, Erlotinib (brand name ‘Tarceva’). After a protracted legal battle fought over seven hard years, Roche finally won. But so did Cipla. Indeed,...
More »
